Marking the formal beginning of the evaluation process for Covid-19 vaccine candidates who have applied for emergency clearance in India, the Central Organization for Standard Medicines decided to seek additional safety and efficacy data from the Serum Institute of India and Bharat Biotech before giving the approval. Pfizer’s request was …
Read More »
No emergency use authorization has been granted to the Serum Institute of India (SII) or Bharat Biotech’s COVID-19 vaccines for lack of data, sources told News18 on Wednesday. Bharat Biotech had on Monday applied to the Controller General of Drugs of India (DCGI) for an emergency use authorization for COVID-19 …
Read More »
The panel reviewed the applications of Pfizer, Serum Institute and Bharat Biotech (Representational) New Delhi: Proposals from the Serum Institute and Bharat Biotech for the use of emergency vaccines have not been approved because of inadequate safety and efficacy data, sources said Wednesday. “Both proposals are not approved due to …
Read More »
The government is pinning its hopes for a massive supply of vaccines to the Serum Institute. (Figurative) Bangalore: The Serum Institute of India, the world’s largest producer of vaccines by volume, is close to signing a supply contract with the Center and will likely set prices at Rs 250 ($ …
Read More »
The Center will bring more than 60 foreign mission chiefs to Bharat Biotech and Biological E, the two biotech companies working on a Covid-19 vaccine tomorrow, people familiar with the matter said Tuesday. Those envoys would be briefed on the progress made by scientists working on the vaccine. Bharat Biotech …
Read More »
Hopes for an early vaccine for coronavirus disease (Covid-19) in India have been rekindled after three companies, within days of each other, applied for emergency use authorization (USA) of their respective candidate vaccines in the country. While Pfizer Inc of the United States was the first to apply on December …
Read More »
A committee of experts from the Central Standard Medicines Control Organization (CDSCO) will meet on Wednesday to review applications from Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorization for their Covid-19 vaccine candidates. official sources said Monday night. The decision was made late Monday night after …
Read More »
NEW DELHI: A committee of experts from the Central Standard Medicines Control Organization (CDSCO) will meet on Wednesday to review applications from Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorization for their vaccine candidates Covid-19, official sources said Monday. night. The decision was made late Monday …
Read More »
Written by Payal Banerjee | New Delhi | Updated: December 7, 2020 10:19:17 am The Serum Institute of India on Sunday requested the Comptroller General of Drugs of India (DCGI) for emergency use authorization for its Oxford Covid-19 vaccine in the country. (PTI file photo) The Serum Institute of India …
Read More »
A senior Health Ministry official told The Hindu that Covishield is logistically more feasible for use and distribution in India, as it stores well between two and eight degrees Celsius. The Serum Institute of India (SII) said on Monday that it had applied to the Controller General of Drugs of …
Read More »